Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1 study found for:    NCT00079066
Show Display Options
Rank Status Study
1 Completed Cetuximab and Best Supportive Care Compared With Best Supportive Care Alone in Treating Patients With Metastatic Epidermal Growth Factor Receptor-Positive Colorectal Cancer
Conditions: Colorectal Cancer;   Quality of Life
Interventions: Biological: cetuximab;   Procedure: quality-of-life assessment

Indicates status has not been verified in more than two years